Machine learning algorithm predicts a tumor's response to immune checkpoint blockade

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades.

Related Keywords

Catherine Wu ,Alexander Baras ,Giacomo Oliveira ,John William Sidhom ,Bristol Myers Squibb ,Emily Henderson ,Petra Ross Macdonald ,Johns Hopkins Kimmel Cancer Center ,Bloomberg Kimmel Institute For Cancer Immunotherapy ,Lab Diagnostics Automation ,Harvard Medical School ,Dana Farber Cancer Institute ,Johns Hopkins University School Of Medicine ,Lab Diagnostics Automation Industry ,Kimmel Institute ,William Sidhom ,Johns Hopkins University School ,Automation Industry Focus ,Drew Pardoll ,Johns Hopkins Kimmel Cancer ,Megan Wind Rotolo ,Cancer ,Ancer Immunotherapy ,Immunotherapy ,Machine Learning ,Amino Acid ,Artificial Intelligence ,Fell ,Deep Learning ,Drugs ,Immune System ,Medicine ,Melanoma ,Ncology ,Mh ,Protein ,Research ,Humor ,Virus ,